331 related articles for article (PubMed ID: 34481143)
1. Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
Feng X; Luo D; Wei G; Zhan F; Hua F; Xu G
Int Immunopharmacol; 2021 Nov; 100():108105. PubMed ID: 34481143
[TBL] [Abstract][Full Text] [Related]
2. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
Shirasuna K; Karasawa T; Takahashi M
J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as important regulators of the NLRP3 inflammasome.
Zamani P; Oskuee RK; Atkin SL; Navashenaq JG; Sahebkar A
Prog Biophys Mol Biol; 2020 Jan; 150():50-61. PubMed ID: 31100298
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
5. Regulation of NLRP3 by non-coding RNAs in different cancers: interplay between non-coding RNAs and NLRP3 in carcinogenesis and metastasis.
Farooqi AA; Attar R; Tanriover G; Sabitaliyevich UY; Zhailganov A; Rabandiyarov M
Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):47-51. PubMed ID: 34174977
[TBL] [Abstract][Full Text] [Related]
6. Functional crosstalk between Long non-coding RNAs and the NLRP3 inflammasome in the regulation of diseases.
Luo D; Liu F; Zhang J; Shao Q; Tao W; Xiao R; Dai W; Qian K
Mol Immunol; 2021 Mar; 131():191-200. PubMed ID: 33446392
[TBL] [Abstract][Full Text] [Related]
7. The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson's disease.
Li Y; Yu C; Jiang X; Fu J; Sun N; Zhang D
Pathol Res Pract; 2024 Jun; 258():155349. PubMed ID: 38772115
[TBL] [Abstract][Full Text] [Related]
8. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs.
Al-Hawary SIS; Jasim SA; Romero-Parra RM; Bustani GS; Hjazi A; Alghamdi MI; Kareem AK; Alwaily ER; Zabibah RS; Gupta J; Mahmoudi R; Hosseini-Fard S
Pathol Res Pract; 2023 Jun; 246():154490. PubMed ID: 37141699
[TBL] [Abstract][Full Text] [Related]
10. Role of NLRP3 inflammasome in inflammatory bowel diseases.
Tourkochristou E; Aggeletopoulou I; Konstantakis C; Triantos C
World J Gastroenterol; 2019 Sep; 25(33):4796-4804. PubMed ID: 31543674
[TBL] [Abstract][Full Text] [Related]
11. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Özenver N; Efferth T
Pharmacol Res; 2021 Aug; 170():105710. PubMed ID: 34089866
[TBL] [Abstract][Full Text] [Related]
12. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
13. Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation.
Ge Q; Chen X; Zhao Y; Mu H; Zhang J
Life Sci; 2021 Feb; 267():118918. PubMed ID: 33352170
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Inflammasome in Acute Myocardial Infarction.
Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 inflammasome as a key driver of vascular disease.
Takahashi M
Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
[TBL] [Abstract][Full Text] [Related]
17. The Long Non-coding RNAs: Paramount Regulators of the NLRP3 Inflammasome.
Menon MP; Hua KF
Front Immunol; 2020; 11():569524. PubMed ID: 33101288
[TBL] [Abstract][Full Text] [Related]
18. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
[TBL] [Abstract][Full Text] [Related]
19. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
20. Enigmatic inflammasomes.
Triantafilou K
Immunology; 2021 Mar; 162(3):249-251. PubMed ID: 33590488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]